Intuity Medical, Inc. (POGO)

Intuity Medical was planning to go public, but the IPO has been withdrawn.
Stock Price: Pending
IPO price not available yet

Company Description

Intuity Medical is a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes.

We developed our first commercial product, the POGO Automatic Blood Glucose Monitoring System, or POGO Automatic, to revolutionize the blood glucose testing process for individuals living with diabetes.

POGO Automatic is an FDA cleared, automated, self-contained handheld monitor that enables patients to accurately measure blood glucose levels within seconds.

POGO Automatic offers full connectivity through our secure cloud-based digital health ecosystem, the Patterns app, which centralizes each patient’s blood glucose testing data in a digital form that can be shared with healthcare providers and others who play a central role in assisting with a patient’s diabetes treatment and testing regimen.

We believe the convenience and simplicity of POGO Automatic will help remove the barriers to traditional glucose testing for people diagnosed with diabetes, and help them achieve their glucose level goals.

Intuity Medical, Inc.
Country United States
Founded 2002
Industry Medical Devices
Sector Health Care
Employees 111
CEO Emory Anderson

Contact Details

Address:
3500 West Warren Avenue
Fremont, CA 94538
United States
Phone (510) 946-8800
Website presspogo.com

Stock Details

Ticker Symbol POGO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 1484074

Key Executives

Name Position
Emory Anderson President, Chief Executive Officer and Director
Timothy Buskey Chief Market Access Officer and Senior Vice President of Market Access and Channel Management
Tammy Cameron Chief Financial Officer and Senior Vice President of Finance and Human Resources
Robb Hesley Chief Operating Officer and Senior Vice President of Product Development, Manufacturing, Quality and Information Technology
Dean Zikria Chief Commercial Officer and Senior Vice President of Sales and Marketing
Rebecca Robertson Chairperson and Director
Michael Bornitz, CFA, CPA Director
Matthew Crawford Director

Latest SEC Filings

Date Type Title
Jun 3, 2022 RW Registration Withdrawal Request
Sep 17, 2021 S-1 General form for registration of securities under the Securities Act of 1933
Aug 31, 2021 DRS/A Draft Registration Statement
Jul 26, 2021 DRS/A Draft Registration Statement
Jun 4, 2021 DRS Draft Registration Statement
May 29, 2019 D Notice of Exempt Offering of Securities
Feb 15, 2018 D/A Notice of Exempt Offering of Securities
Jan 10, 2018 D Notice of Exempt Offering of Securities
Jan 9, 2017 D/A Notice of Exempt Offering of Securities
Nov 9, 2016 D Notice of Exempt Offering of Securities